ALC-2203

· Korea Arlico Pharm. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALC-2203, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis [Phase 2]